相关实验视频
Updated: Jan 18, 2026

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
1.0K
通过抑制TLR4/Myd88/NF-κB和P38/MAPK通路来改善实验性类风湿性关节炎
概括
在大鼠模型中,击败乌比丁D (UBD) 显著降低了类风湿性关节炎 (RA) 的进展. 这表明UBD是一种潜在的治疗标和RA的生物标志物.
科学领域:
- 类风湿病学 类风湿病学
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 乌比奎D (UBD) 在癌症中过度表达,但其在类风湿性关节炎 (RA) 中的作用尚不清楚.
- 了解UBD在RA中的机制对于开发新疗法至关重要.
研究的目的:
- 研究乌比丁D (UBD) 在类风湿性关节炎 (RA) 中的治疗潜力.
- 阐明UBD在RA进展中的作用的潜在机制.
主要方法:
- 使用了原诱导性关节炎 (CIA) 的老鼠模型.
- 采用了组织学分析 (H&E,Safranin O,TRAP染色) 和生化分析 (ELISA,Western blot).
主要成果:
- UBD knockdown 降低了软骨/骨质侵蚀和骨质细胞活动.
- 观察到炎症标志物 (PGE2,TNF-α,IL-1β,IL-6,MMP-9) 和信号通路 (p38,TLR4,NF-κB) 的下调.
- 在中情局老鼠中,UBD敲击改善了软骨完整性.
结论:
- 在中央情报局的老鼠模型中,UBD Knockdown显著缓解了关节炎的进展.
- 抑制UBD是一种对RA有前途的治疗策略.
- UBD可以作为一种有价值的风湿性关节炎预后生物标志物.
相关概念视频
The JAK-STAT Signaling Pathway
12.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
12.2K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
506
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
506
TGF - β Signaling Pathway
10.5K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.5K
T Cell Types and Functions
2.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.2K
Receptor Downregulation in MVBs
2.8K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.8K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
495
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
495

